Acute Tubular Necrosis
From Anvita Health Wiki
Contents |
Etiology
-
- hypovolemia
- low cardiac output
- renal vasoconstriction
- systemic vasodilatation
- obstetric complications
- recent hemorrhage
- hypotension
- surgery (30%) [7]
- pharmaceutical agents ( nephrotoxic agents)
- aminoglycosides
- amphotericin B
- colistin
- cyclosporine
- methoxyflurane
- polymixins
- radioiodinated contrast medium
- sulfonamides
- tetracyclines
- cisplatin
- acetaminophen
Epidemiology
- most common form of acute renal failure
Pathology
- oliguric phase
- intratubular obstruction secondary to oncosis of renal tubular epithelial cells
- backleak of glomerular filtrate through a disrupted proximal tubular barrier
- decreased glomerular permeability & GFR
- diuretic phase
- improved GFR
- inability of regenerating tubules to reabsorb Na+ & water normally
- alterations in fluid & electrolyte balance may occur
Clinical-manifestations
-
- duration 1-2 weeks
- seldom > 4 weeks
- consider biopsy to seek other causes of renal failure if oliguric phase lasts more than 4 weeks
- diuretic phase
- increases in urine flow not necessarily associated with improvement in serum creatinine early
- serum creatinine improves as glomerular filtration rate ( GFR) increases
- severe hypercalcemia may occur in rhabdomyolysis-induced renal failure during this phase
- recovery phase
- glomerular filtration rate improves over 3-12 months
- generally, GFR stabilizes at a reduced rate, especially in patient who have been oliguric for > 16 days
Laboratory
-
- muddy brown granular or tubular epithelial cell casts
- urinary [[[Na+]]] > 20 meq/L
- specific gravity < 1.015
- fractional excretion of sodium ( FENA) > 2% [4]
- urine osmolality similar to serum osmolality
- urine creatinine is generally low ( oliguric phase)
- serum chemistries
- K+ ( hyperkalemia)
- phosphorous ( hyperphosphatemia)
- Ca+2 ( hypocalcemia)
- uric acid ( hyperuricemia)
- myoglobin (increased)
- creatine kinase (increased)
- Na+ ( hyponatremia)
- HC03- ( metabolic acidosis)
- urea nitrogen ( uremia)
- serum creatinine (increased)
- serum protein electrophoresis ( SPE)/immunofixation electrophoresis ( IFE) if indicated
- osmolal gap (if ethylene glycol is suspected)
Complications
- infection is the most common morbidity
- GI bleeding ( platelet dysfunction secondary to uremia)
- hypervolemia with congestive heart failure ( CHF)
- hyponatremia
Management
- restore systemic hemodynamics & renal perfusion
- eliminate nephrotoxins
- consider specific methods
- forced alkaline diuresis to remove uric acid, myoglobin ( rhabdomyolysis), methotrexate
- chelation therapy
- hemodialysis [5] QD is better than QOD
- fenoldopam may benefit a subgroup of patients [6]
- once injured, renal tubular epithelial cells take 3-4 weeks to regenerate
- dialysis
- fluid & electrolyte management
- once tubular regeneration occurs, the patient enters a diuretic phase
- trial of low dose (renal) dopamine plus Lasix
- prognosis: non oliguric patients have better prognosis than oliguric patients
- see acute renal failure
More General Terms
Additional Terms
References
- Harrison's Principles of Internal Medicine, 13th ed. Companion Handbook, Isselbacher et al (eds), McGraw-Hill Inc. NY, 1995, pg 829-39
- Harrison's Principles of Internal Medicine, 14th ed. Fauci et al (eds), McGraw-Hill Inc. NY, 1998, pg 1504-1513
- Applied Laboratory Medicine, Teitz NW, Conn RB & Pruden EL editors, WB Saunders, Philadelphia, 1992
- Medical Knowledge Self Assessment Program (MKSAP) 11, 15, American College of Physicians, Philadelphia 1998, 2009
- Journal Watch 22(5):38, 2002 Schiffl H et al Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346:305, 2002 PMID: [1] Bonventre JV et al, Daily hemodialysis-will treatment each day improve the outcome in patients with acute renal failure? N Engl J Med 346:362, 2002 PMID: [2]
- Journal Watch 25(17):135, 2005 Tumlin JA, Finkel KW, Murray PT, Samuels J, Cotsonis G, Shaw AD. Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial. Am J Kidney Dis. 2005 Jul;46(1):26-34. PMID: [3]
- Geriatric Review Syllabus, 7th edition Parada JT et al (eds) American Geriatrics Society, 2010
